You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Alignment Tolerant Optical Connector with Active Regenerative Element
SBC: ULTRA COMMUNICATIONS, INC. Topic: A12AT008This program creates a new class of advanced transceiver techology. This technology can create 40 Gbps VCSEL-based micro-transceiver (uTRX) components that operate reliably over the standard military temperature range of -55°C to 125°C in Army environments. uTRXs are low-cost, compact components that can be assembled onto the PCB in close proximity to high-performance ASICs using conventional ...
STTR Phase II 2013 Department of DefenseArmy -
A Luminal Vascular Coating to Prevent Intimal Hyperplasia Following Creation of a
SBC: Symic Bio, Inc. Topic: NIDDKDESCRIPTION (provided by applicant): This proposal addresses PHS 2012-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42]). More than 20 million American adults (1 in 10) have some level of chronic kidney disease (CDC), with a growing incidence in the aging population. Nearly 400,000 ESRD patients receive some form of dialysis, with t ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
An automated and programmable microfluidic platform for combinatorial gene assembly and biosynthesis applications
SBC: HJ SCIENCE & TECHNOLOGY INC Topic: ST12B003HJ Science & Technology (HJS & T) and the Joint BioEnergy Institute (JBEI) propose to develop an automated, software-controlled, programmable, low-cost, and compact platform capable of running rapid and complex bioengineering processes and optimization of new biomanufacturing systems. Our approach combines the microfluidic automation technology of HJS & T with the novel synthetic biology technolo ...
STTR Phase I 2013 Department of DefenseDefense Advanced Research Projects Agency -
An improved passivation process for the fabrication of high performance antimony based III-V superlattice materials
SBC: IRDT Solutions, Inc Topic: MDA12T003Phase I objective is to demonstrate the feasibility of our proposed passivation approach to minimize the dark current noise and improve the quantum efficiency in the GaSb based type II superlattice detectors. Phase I goal is to demonstrate the feasibility of our technology to fabricate photodiodes with cut-off wavelength in excess of 10µm, quantum efficiency exceeding 70% and dark current density ...
STTR Phase I 2013 Department of DefenseMissile Defense Agency -
An intravaginal ring for real-time evaluation of adherence to topical vagina
SBC: AURITEC PHARMACEUTICALS, INC. Topic: NIAIDDESCRIPTION (provided by applicant): The broad long-term of this project is to develop methods for evaluation of adherence to intravaginal microbicide therapy for the prevention of HIV transmission. Correct determination of adherence to preventative therapies in clinical trials is essential to accurate evaluation of efficacy. A better understanding of the true adherence to a preventative therapy w ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
A noninvasive optical imaging of retinal amyloid beta deposits in AD patients
SBC: NEUROVISION IMAGING, LLC Topic: NIADESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a progressive and invariably fatal degenerative dementia and the most common form of dementia that currently affects over 5 million Americans. The quality of life and economic costs are significant with estimated U.S. health care payments of over 200 billion in 2012, plus unpaid care by over 15 million Americans that is valued ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
A Novel Brachytherapy Agent for GBM
SBC: APPLIED INTEGRIN SCIENCES, INC. Topic: NCIDESCRIPTION (provided by applicant): Despite advances in surgery, chemotherapy, and radiation therapy, the average life span of a patient with glioblastoma multiforme (GBM) is about 15-months from time of diagnosis. Integrins are heterodimeric receptors found on the surface of GBM cells and angiogenic vasculature; they facilitate invasion into adjacent tissue. Normal brain tissue does not display ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
A Priori Error-Controlled Simulations of Electromagnetic Phenomena for HPC
SBC: HYPERCOMP INC Topic: A11aT015Recent times have witnessed enormous advances in high fidelity modeling of electromagnetic (EM) phenomena in the time-domain. To make such simulations tractable, the computational region must be truncated in a manner allowing outgoing waves to leave with minimal reflection from the boundary. HyPerComp Inc., in collaboration with Prof. Thomas Hagstrom of the Southern Methodist University (Dallas, T ...
STTR Phase II 2013 Department of DefenseArmy -
A safer urinary catheter design to reduce catheter trauma and infections
SBC: SAFE MEDICAL DESIGN, LLC Topic: NIDDKDESCRIPTION (provided by applicant): In today's device world, products must address soaring healthcare costs under the increased scrutiny of quality and safety. By addressing patient safety, we believe costs can be reduced and quality improved. Non-infectious urethral catheter related complications are one such patient safety problem the US and worldwide health care industry faces. Urethral c ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
A user-friendly scalable microfluidic platform for enhanced neuron-cell culture
SBC: Xona Microfluidics, Inc. Topic: NIMHDESCRIPTION (provided by applicant): Neuron-cell culture is widely used for studies in basic research, drug discovery, and toxicity testing. Traditional random cultures allow limited access to subcellular compartments (axons, dendrites, synapses) due to extensive and haphazard growth of neurons. Our long-term goal is to provide robust, user-friendly, and cost effective culture platforms that can o ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health